Skip to main content
. 2016 Sep 17;7(43):69976–69990. doi: 10.18632/oncotarget.12099

Figure 1. Distribution of staining-based FGFR4 and RAD51 expression in pre-neoadjuvant rectal cancer biopsies.

Figure 1

Representative staining of biopsies exhibiting negative, weak, moderate and strong FGFR4 (A) or RAD51 (B) staining. Rectal cancer tissues were classified according to overall staining intensity for FGFR4 (C) and RAD51 (D), based on slide scans and morphometric analysis. Scale bar = 50 μm.